Protection by spironolactone and oxandrolone against chronic digitoxin or indomethacin intoxication.
D000818:Animals; D004074:Digitoxin / Q000037:antagonists & inhibitors* / Q000097:blood / Q000633:toxicity*; D004336:Drug Antagonism; D005260:Female; D007213:Indomethacin / Q000037:antagonists & inhibitors* / Q000097:blood / Q000633:toxicity*; D007410:Intestinal Diseases / Q000139:chemically induced; D007583:Jejunum; D008862:Microsomes, Liver / Q000201:enzymology; D009026:Mortality; D010074:Oxandrolone / Q000627:therapeutic use*; D011335:Proadifen / Q000494:pharmacology; D051381:Rats; D012640:Seizures / Q000139:chemically induced; D013148:Spironolactone / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D014456:Ulcer / Q000139:chemically induced
D013148:Spironolactone; D010074:Oxandrolone; D011335:Proadifen; D004074:Digitoxin; D007213:Indomethacin